ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132 | +34.7% | 6,361 | +54.2% | 0.00% | – |
| Q2 2023 | $98 | +71.9% | 4,125 | +35.8% | 0.00% | – |
| Q1 2023 | $57 | -99.9% | 3,037 | -17.7% | 0.00% | – |
| Q3 2022 | $60,000 | -16.7% | 3,689 | +18.4% | 0.00% | – |
| Q4 2021 | $72,000 | +67.4% | 3,115 | +19.4% | 0.00% | – |
| Q3 2021 | $43,000 | -40.3% | 2,609 | +92.4% | 0.00% | – |
| Q4 2020 | $72,000 | +30.9% | 1,356 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -67.8% | 1,356 | -66.6% | 0.00% | – |
| Q1 2020 | $171,000 | -93.5% | 4,060 | -93.4% | 0.00% | -100.0% |
| Q4 2019 | $2,645,000 | +9020.7% | 61,846 | +7488.5% | 0.00% | – |
| Q3 2019 | $29,000 | – | 815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |